This point is important because these TDP‐43‐dependent cryptic exon splicing events in ALS and FTD might now allow the field to be able to detect the earliest events of TDP‐43 pathology and will suggest not only disease mechanisms but also novel therapeutic targets. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.